Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
Conditions
- Recurrent Chronic Myelomonocytic Leukemia
- Refractory Chronic Myelomonocytic Leukemia
- Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified
- Recurrent Atypical Chronic Myeloid Leukemia
- Recurrent Myelodysplastic/Myeloproliferative Neoplasm
- Refractory Myelodysplastic/Myeloproliferative Neoplasm
Interventions
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Bone Marrow Aspiration and Biopsy
- DRUG: Onvansertib
- PROCEDURE: Ultrasound Imaging
Sponsor
Mayo Clinic
Collaborators